about
GWAS of 126,559 individuals identifies genetic variants associated with educational attainmentToward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseA common polymorphism near PER1 and the timing of human behavioral rhythmsAccumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersAt the interface of sensory and motor dysfunctions and Alzheimer's disease.Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets.Association of Long Runs of Homozygosity With Alzheimer Disease Among African American IndividualsRarity of the Alzheimer disease-protective APP A673T variant in the United StatesNovel genetic loci underlying human intracranial volume identified through genome-wide associationThe effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort studyREST and stress resistance in ageing and Alzheimer's diseaseA longitudinal study of implicit and explicit memory in old personsCognitive and social lifestyle: links with neuropathology and cognition in late lifeIrregular 24-hour activity rhythms and the metabolic syndrome in older adultsClinical-pathologic study of depressive symptoms and cognitive decline in old ageGenetic variants in Alzheimer disease - molecular and brain network approachesGWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortiumThe Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementiaIntermediate phenotypes identify divergent pathways to Alzheimer's diseaseCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses.Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium.Early life instruction in foreign language and music and incidence of mild cognitive impairment.Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association studyGBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.Brain amyloid-β oligomers in ageing and Alzheimer's disease.Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.Cerebral amyloid angiopathy and cognitive outcomes in community-based older personsGenetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.Ex vivo T2 relaxation: associations with age-related neuropathology and cognitionIndependent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United StatesSigmoidal mixed models for longitudinal data.The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriersAssociations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adults.
P50
Q24289119-285BD896-26BE-4F80-A431-613C61095BCEQ24595802-169470D5-2F04-4F9C-B562-AD2943414F18Q24630975-5AB2EAD5-E5B9-4776-9811-A281ACA5BB0EQ24634907-37F30CD7-608D-4059-81B3-04A69F8FEF3BQ26745508-F96E0E33-B427-46FE-BFDE-18E64CA4F3C0Q27000410-F2A46F2E-56BD-472F-A794-6294F21F7852Q27345159-DFCFFE29-3437-4C5D-83C6-AB5D03456C32Q27345314-F2F56543-4E71-426B-A5A2-888C02E14AD5Q27346292-5555B602-2061-4588-A58B-B518DD928451Q27653381-1C617EDE-E151-4F0D-B97A-C07F30A0D38BQ28236050-106A8D91-B071-4203-8FC7-33483F1474F3Q28236857-5D552170-5E8D-4F27-A4EB-804E5355CF77Q28297174-5E643FE8-EBC5-4B70-88DA-C757B79BA690Q28304421-0E068396-6971-4EBA-A3BC-70B1D3BFA49CQ28386172-D04A7AF5-86E7-4BDF-8795-EC5B8BE67F4CQ28393370-7CB27619-A097-4AA9-8411-1462C5118B66Q28596011-EE9D39E5-9929-4EB4-82B6-11BD7F53D388Q28596242-6977A67F-326A-4555-BB4A-62227824E0B9Q28728646-84932789-CA09-46A5-9710-47B181EB2A6CQ28751409-11934D86-2AF6-41B4-BBEB-2A46F695FEB7Q28943325-76AE2C65-BC6E-4D83-8462-619F5C68C5E3Q29416991-48F3AAD0-C00C-489E-A056-892FAC1686DEQ29417099-A3444A49-2884-4C2D-82CC-EB8FED9651CAQ29417137-4EB9FF74-D7BA-4961-AFF0-4CEFBA49AB19Q30276970-E6B0394F-A3B2-46A7-BB9E-BDA291754903Q30276980-B3EC66D9-840C-45A8-A773-8D769170DA0FQ30300864-1C9FFFA2-2E9B-45B1-85CD-BB3B844EEE11Q30365567-8845B9F6-4459-40F9-8EF9-81EA3E03236DQ30434949-60947254-1F96-4F9C-B07E-D42CFB987174Q30459046-9DA5A0DB-C94F-459F-B10E-39836BE0B54DQ30527838-B04FB732-A17E-4BB5-AAA2-06CC7F998BD7Q30539133-E5AE943E-9F54-4112-A872-119C81538E3DQ30540165-0123615E-D93F-4061-B3B7-2A522BB92688Q30683853-D41046A5-E71C-44E6-AFC0-119DDDADDC3CQ30688472-AFCB3241-E488-4E40-95B6-F9C3D2A6BCF7Q30767891-2015634B-5C63-4A42-8B15-B7001F835EFCQ31049097-BE08B8FE-1B6E-4EF1-B5EA-2E0CFBF9B721Q31088187-F4A0BFB6-74F0-4737-AFAE-32AB90A211D9Q31129910-801E175C-7F32-478C-8DCA-66902FAB961AQ31148852-2B8722D5-FFDF-44AA-BF71-2EAF19AEDB2B
P50
name
David A Bennett
@ast
David A Bennett
@en
David A Bennett
@nl
type
label
David A Bennett
@ast
David A Bennett
@en
David A Bennett
@nl
prefLabel
David A Bennett
@ast
David A Bennett
@en
David A Bennett
@nl
P214
1155148705738737080003
P31
P734
P7859
viaf-1155148705738737080003